Skip to main content

Table 1 Patient demographics and preoperative parameters

From: Laparoscopic total pelvic exenteration for pelvic malignancies: the technique and short-time outcome of 11 cases

Patient no.

Gender

Age

BMI

Preoperative diagnosis

Preoperative complications

nCRT

ASA

1

Male

57

25.3

Bladder transitional cell carcinoma (grade 3) and rectal adenocarcinoma

Lower gastrointestinal bleeding

No

2

2

Male

62

23.5

Prostate sarcoma (recurrent)

Difficult defecation

No

2

3

Male

58

19.9

Sigmoid adenocarcinoma (bladder invasion)

Rectovesical fistula Colonic obstruction

No

2

4

Male

62

23.3

Rectal adenocarcinoma (bladder invasion)

Rectovesical fistula

No

2

5

Male

75

25.9

Bladder transitional cell carcinoma (grade 2) and rectal adenocarcinoma

Acute renal insufficiency Hypertension

No

2

6

Female

69

21.7

Sigmoid adenocarcinoma (bladder and uterus invasion)

Hypertension

No

2

7

Female

55

23.4

Sigmoid adenocarcinoma (bladder invasion)

Rectovesical fistula

No

2

8

Male

44

24.7

Rectal adenocarcinoma (bladder invasion)

Renal calculi

No

2

9

Female

65

22.3

Sigmoid adenocarcinoma (bladder invasion)

Diabetes mellitus

No

2

10

Male

71

25.1

Sigmoid adenocarcinoma (bladder invasion)

Benign prostatic hyperplasia colonic obstruction

No

2

11

Male

30

20.2

Rectal adenocarcinoma (bladder invasion)

Rectal obstruction

No

2

Mean

 

58.9 (median, 62)

23.2

    
  1. nCRT neoadjuvant chemoradiotherapy, ASA American Standards Association, BMI body mass index